The success of Viagra initially drove a surge for pharma, however recent changes present a complicated scenario for shareholders. Generic alternatives are eating into revenue, and ongoing legal battles add additional https://jeanotfe970459.ambien-blog.com/48045390/the-blue-pill-and-pharma-a-risky-play